Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer

Chew, Helen Kent; Schwartzberg, Lee; Badarinath, Suprith; Rubin, Peter; Shumaker, Grace; Daugherty, James; DeSilvio, Michelle; Mahoney, Janine

doi:10.1186/2193-1801-3-108

SpringerPlus

Article metrics
Last updated: Fri, 26 Apr 2024 21:42:15 Z

Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer

Access & Citations

1532

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.